Applied Optoelectronics (AAOI) has drawn attention after a sharp 17.7% one day move, building on its strong performance over the past month and past three months, prompting investors to reassess its valuation and recent financial profile.

That sharp 1 day move sits on top of a 30 day share price return of 41.74% and a 90 day share price return of 354.00%. At the same time, the 1 year total shareholder return is very large, pointing to powerful momentum rather than a short term spike.

If you are watching AAOI and want to see what else is moving in related areas, this is a good time to scan 38 AI infrastructure stocks

With AAOI up sharply and trading well above the average analyst price target, the key question now is whether the recent surge leaves the shares stretched or if the market is still only starting to price in future growth.

Most Popular Narrative: 107.9% Overvalued

At a last close of $162.17 versus a narrative fair value of $78.00, the most followed thesis on Applied Optoelectronics argues that recent pricing sits well above its estimated worth while still hinging on strong growth and margin assumptions.

At about US$6.6 to 6.7b market cap, AAOI trades around:

• roughly 14x to 15x trailing sales based on 2025 revenue of US$455.7M, and

• roughly 6.5x forward sales if management achieves US$1b+ revenue in 2026.

That means the stock is expensive on backward numbers but less extreme if the 2026 revenue target is real and sustainable. The market is effectively underwriting:

• a successful 800G scale ramp,

• on-time 1.6T commercialization,

• margin expansion from low-30s gross margin toward a stronger operating profile, and

• no major customer reset.

Want to see what keeps this growth story on track at a fair value below today’s price? According to HedgeY, the narrative leans on aggressive revenue scaling, fatter margins and a future earnings profile that assumes those hyperscaler orders translate cleanly into profits. Curious which financial levers matter most if that ramp hits a bump, or overdelivers.

Result: Fair Value of $78.00 (OVERVALUED)

However, this hinges on concentrated hyperscaler demand and an ambitious jump to US$1b revenue in 2026. Any delay or order setback could quickly test that premium pricing.

Next Steps

Sentiment looks split, with sharp gains on one side and real execution questions on the other. Act while the data is fresh and weigh the 1 key reward and 3 important warning signs

Looking for more investment ideas?

If AAOI has your attention, do not stop here, fresh opportunities often sit just outside the obvious names and you will not want to miss them.

• Target potential mispricings by scanning 56 high quality undervalued stocks that combine quality fundamentals with prices that may not fully reflect their profiles yet.
• Prioritise resilience by checking 72 resilient stocks with low risk scores where companies score well on financial stability and risk factors that many investors overlook.
• Spot early standouts by reviewing the screener containing 24 high quality undiscovered gems before they appear on everyone else's radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.